Amgen Inc (AMGN)
$333.80-0.80%
Spriggl Score: Good— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Fourteen blockbusters, strong cash flow, debt lifting; MariTide Phase 3 is the decisive chapter.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque ps…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - General
- Market Cap:
- $181.4B
Recent dividends
- 15 May 2026$2.52
- 13 Feb 2026$2.52
- 21 Nov 2025$2.38
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Amgen Inc and 1,600+ UK and US stocks.
Start free